Which has grown faster, PCRX or PRCT?

Over the past five years, PRCT grew revenue faster — PCRX at a 8.20% CAGR versus PRCT at 74.27%.

Is PCRX or PRCT more profitable?

PCRX runs the higher net margin — PCRX at 1.96% versus PRCT at -32.54%.

How have PCRX and PRCT total returns compared?

Over the past 5 years, PCRX delivered -12.27% and PRCT delivered -14.36% annualized total return. Past performance doesn't predict future results.

Pacira BioSciences, Inc. (PCRX) vs PROCEPT BioRobotics Corporation (PRCT)

A side-by-side comparison of Pacira BioSciences, Inc. and PROCEPT BioRobotics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

PCRX

Pacira BioSciences, Inc.

$973M

$24.74HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT

PRCT

PROCEPT BioRobotics Corporation

$984M

$17.28HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT

Total return — PCRX vs PRCT

growth of $100 · dividends reinvested · last 5y

PCRX -54.8% (-14.7%/yr)PRCT -57.5% (-15.7%/yr)PCRX compounded faster over this window

PCRX PRCT

PCRX vs PRCT: by the numbers

•PRCT is the larger company ($984M vs $973M market cap).
•PCRX is profitable (1.96% net margin) while PRCT runs a net loss (-32.54%).
•PRCT grew revenue faster over the past five years (74.27% vs 8.20% CAGR).

Metrics side by side

Valuation

Metric	PCRX	PRCT
P/E ratio	70.42	N/A
P/S ratio	1.30	2.92
P/B ratio	1.45	2.89
EV / EBITDA	11.38	N/A
FCF yield	18.45%	N/A

Profitability

Metric	PCRX	PRCT
Gross margin	79.21%	63.74%
Operating margin	2.47%	-33.86%
Net margin	1.96%	-32.54%
ROE	2.18%	-32.27%
ROIC	1.35%	-27.51%

Growth (annualized)

Metric	PCRX	PRCT
Revenue CAGR (5Y)	8.20%	74.27%
EPS CAGR (5Y)	-45.77%	N/A
FCF CAGR (5Y)	16.72%	N/A
Total return CAGR (5Y)	-12.27%	-14.36%

Frequently asked

Which has grown faster, PCRX or PRCT?: Over the past five years, PRCT grew revenue faster — PCRX at a 8.20% CAGR versus PRCT at 74.27%.
Is PCRX or PRCT more profitable?: PCRX runs the higher net margin — PCRX at 1.96% versus PRCT at -32.54%.
How have PCRX and PRCT total returns compared?: Over the past 5 years, PCRX delivered -12.27% and PRCT delivered -14.36% annualized total return. Past performance doesn't predict future results.

Go deeper

Full PCRX analysis Full PRCT analysis Interactive comparison tool

Dig into the metrics

Pacira BioSciences P/E ratio Pacira BioSciences ROE PROCEPT BioRobotics ROE Pacira BioSciences operating margin PROCEPT BioRobotics operating margin Pacira BioSciences revenue growth PROCEPT BioRobotics revenue growth Pacira BioSciences free cash flow PROCEPT BioRobotics free cash flow

Pacira BioSciences & PROCEPT BioRobotics appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.